Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Improving Sleep and Alzheimer's Disease (AD) Biomarkers: A Pilot Randomized Clinical Trial (RCT) of Citicoline

NCT06029894 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT06029894
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06029894 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Improving Sleep and Alzheimer's Disease (AD) Biomarkers: A Pilot Randomized Clinical Trial (RCT) of Citicoline
Lead sponsor
Emory University
Phase
Not applicable
Overall status
Completed
Start date
December 15, 2023
Completion date
December 21, 2025
Enrollment
100 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer disease, mild cognitive impairment